About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Cancer Gene Therapy
›
top-articles
Cancer Gene Therapy
5.7
(top 5%)
impact factor
2.5K
(top 10%)
papers
74.1K
(top 5%)
citations
97
(top 5%)
h
-index
6.1
(top 5%)
impact factor
2.9K
all documents
78.1K
doc citations
136
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
Cancer Gene Therapy
2005
617
2
Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
Cancer Gene Therapy
2021
444
3
Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma
Cancer Gene Therapy
1999
324
4
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin
Cancer Gene Therapy
2006
313
5
siRNA-based approaches in cancer therapy
Cancer Gene Therapy
2006
308
6
MicroRNA and drug resistance
Cancer Gene Therapy
2010
281
7
Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients
Cancer Gene Therapy
2003
277
8
MicroRNA profile analysis of human prostate cancers
Cancer Gene Therapy
2009
251
9
Role of anti-oncomirs miR-143 and -145 in human colorectal tumors
Cancer Gene Therapy
2010
251
10
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials
Cancer Gene Therapy
2002
236
11
Oncolytic herpes simplex virus vectors for cancer virotherapy
Cancer Gene Therapy
2002
235
12
Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
Cancer Gene Therapy
2008
230
13
A comparison of gene transfer methods in human dendritic cells
Cancer Gene Therapy
1997
227
14
Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumors
Cancer Gene Therapy
2000
213
15
Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth
Cancer Gene Therapy
2009
209
16
The ERBB3 receptor in cancer and cancer gene therapy
Cancer Gene Therapy
2008
204
17
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
Cancer Gene Therapy
2016
203
18
Drug sensitivity ("suicide") genes for selective cancer chemotherapy
Cancer Gene Therapy
1994
202
19
Key chemokines direct migration of immune cells in solid tumors
Cancer Gene Therapy
2022
186
20
Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells
Cancer Gene Therapy
2004
176
21
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
Cancer Gene Therapy
2006
176
22
Short interfering RNAs as a tool for cancer gene therapy
Cancer Gene Therapy
2005
175
23
Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer
Cancer Gene Therapy
2017
175
24
Suppression of growth and transformation and induction of apoptosis by EGR-1
Cancer Gene Therapy
1998
175
25
Development and application of adenoviral vectors for gene therapy of cancer
Cancer Gene Therapy
1999
173
26
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer
Cancer Gene Therapy
2002
171
27
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer
Cancer Gene Therapy
2006
165
28
Cancer-associated fibroblasts: overview, progress, challenges, and directions
Cancer Gene Therapy
2021
165
29
High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus
Cancer Gene Therapy
1994
164
30
Prospects for CD40-directed experimental therapy of human cancer
Cancer Gene Therapy
2003
160
31
CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo
Cancer Gene Therapy
2005
160
32
Viral vector systems for gene therapy
Cancer Gene Therapy
1994
157
33
Nanovector delivery of siRNA for cancer therapy
Cancer Gene Therapy
2012
156
34
New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles
Cancer Gene Therapy
2017
155
35
Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of a thymidine kinase-deleted mutant
Cancer Gene Therapy
2000
152
36
Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides
Cancer Gene Therapy
2000
151
37
Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo
Cancer Gene Therapy
2005
151
38
Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
Cancer Gene Therapy
2011
151
39
Towards a commercial process for the manufacture of genetically modified T cells for therapy
Cancer Gene Therapy
2015
151
40
Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells
Cancer Gene Therapy
2007
150
41
Heat-inducible TNF-α gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy
Cancer Gene Therapy
2001
146
42
MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer
Cancer Gene Therapy
2017
146
43
Targeting of adenoviral vectors through a bispecific single-chain antibody
Cancer Gene Therapy
2000
145
44
Transcription factors in ferroptotic cell death
Cancer Gene Therapy
2020
141
45
Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine
Cancer Gene Therapy
2006
140
46
mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes
Cancer Gene Therapy
2007
140
47
Recent advances in p53 research: an interdisciplinary perspective
Cancer Gene Therapy
2009
140
48
RNA viruses as virotherapy agents
Cancer Gene Therapy
2002
139
49
Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients
Cancer Gene Therapy
2009
139
50
Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors
Cancer Gene Therapy
2007
135
site/software ©
exaly
; All materials licenced under
CC by-SA
.